To determine the risk of active tuberculosis associated with human immunodeficiency virus (HIV) infection, we prospectively studied 520 intravenous drug users enrolled in a methadone-maintenance program. Tuberculin skin testing and testing for HIV antibody were performed in all subjects. Forty-nine of 217 HIV-seropositive subjects (23 percent) and 62 of 303 HIV-seronegative subjects (20 percent) had a positive response to skin testing with purified protein derivative (PPD) tuberculin before entry into the study. The rates of conversion from a negative to a positive PPD test were similar for seropositive subjects (15 of 131; 11 percent) and seronegative subjects (26 of 202; 13 percent) who were retested during the follow-up period (mean, 22 months). Active tuberculosis developed in eight of the HIV-seropositive subjects (4 percent) and none of the seronegative subjects during the study period (P less than 0.002). Seven of the eight cases of tuberculosis occurred in HIV-seropositive subjects with a prior positive PPD test (7.9 cases per 100 person-years, as compared with 0.3 case per 100 person-years among seropositive subjects without a prior positive PPD test; rate ratio, 24.0; P less than 0.0001). We conclude that, although the prevalence and incidence of tuberculous infection were similar for both HIV-seropositive and HIV-seronegative intravenous drug users, the risk of active tuberculosis was elevated only for seropositive subjects. These data also suggest that in HIV-infected persons tuberculosis most often results from the reactivation of latent tuberculous infection; our results lend support to recommendations for the aggressive use of chemoprophylaxis against tuberculosis in patients with HIV infection and a positive PPD test.
Source Information
Department of Epidemiology and Social Medicine, Montefiore Medical Center-Albert Einstein College of Medicine, New York 10467.
This article has been cited by other articles:
Camuset, G., Lefebvre, N., Christmann, D., Forestier, E., Faure, B., Boileau, J., Chenard, M. P., Hansmann, Y.
(2009). Disseminated bacille Calmette-Guerin infection in two patients with CD8+ T-cell lymphopenia. Eur Respir J
34: 1199-1201
[Full Text]
Richeldi, L., Losi, M., D'Amico, R., Luppi, M., Ferrari, A., Mussini, C., Codeluppi, M., Cocchi, S., Prati, F., Paci, V., Meacci, M., Meccugni, B., Rumpianesi, F., Roversi, P., Cerri, S., Luppi, F., Ferrara, G., Latorre, I., Gerunda, G. E., Torelli, G., Esposito, R., Fabbri, L. M.
(2009). Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients. Chest
136: 198-204
[Abstract][Full Text]
Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., Bossink, A., Magdorf, K., Holscher, C., Kampmann, B., Arend, S. M., Detjen, A., Bothamley, G., Zellweger, J. P., Milburn, H., Diel, R., Ravn, P., Cobelens, F., Cardona, P. J., Kan, B., Solovic, I., Duarte, R., Cirillo, D. M., C. Lange for the TBNET,
(2009). LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J
33: 956-973
[Abstract][Full Text]
Tseng, S.-H., Jiang, D. D.-S., Hoi, H.-S., Yang, S.-L., Hwang, K.-P.
(2009). Impact of HAART Therapy on Co-Infection of Tuberculosis and HIV Cases for 9 Years in Taiwan. Am J Trop Med Hyg
80: 675-677
[Abstract][Full Text]
Karam, G. H.
(2009). Infections in AIDS Patients and Other Immunocompromised Hosts. ACCP Crit Care Med Brd Rev
20: 13-40
[Full Text]
Li, A. H., Lam, W. L., Stokes, R. W.
(2008). Characterization of genes differentially expressed within macrophages by virulent and attenuated Mycobacterium tuberculosis identifies candidate genes involved in intracellular growth. Microbiology
154: 2291-2303
[Abstract][Full Text]
Marks, S. M., Murrill, C., Sanchez, T., Liu, K.-l., Finlayson, T., Guilin, V.
(2008). Self-Reported Tuberculosis Disease and Tuberculin Skin Testing in the New York City House Ballroom Community. AJPH
98: 1068-1073
[Abstract][Full Text]
Albalak, R., O'Brien, R. J., Kammerer, J. S., O'Brien, S. M., Marks, S. M., Castro, K. G., Moore, M.
(2007). Trends in Tuberculosis/Human Immunodeficiency Virus Comorbidity, United States, 1993-2004. Arch Intern Med
167: 2443-2452
[Abstract][Full Text]
Rennie, T. W., Bothamley, G. H., Engova, D., Bates, I. P.
(2007). Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J
30: 728-735
[Abstract][Full Text]
Maglione, P. J., Xu, J., Chan, J.
(2007). B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis. J. Immunol.
178: 7222-7234
[Abstract][Full Text]
Menzies, D., Pai, M., Comstock, G.
(2007). Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. ANN INTERN MED
146: 340-354
[Abstract][Full Text]
FIERER, J.
(2006). MDR-TB AND HIV: THE PERFECT STORM?. Am J Trop Med Hyg
75: 1025-1026
[Full Text]
Mathema, B., Kurepina, N. E., Bifani, P. J., Kreiswirth, B. N.
(2006). Molecular Epidemiology of Tuberculosis: Current Insights. Clin. Microbiol. Rev.
19: 658-685
[Abstract][Full Text]
Macaraig, M., Agerton, T., Driver, C. R., Munsiff, S. S., Abdelwahab, J., Park, J., Kreiswirth, B., Driscoll, J., Zhao, B.
(2006). Strain-Specific Differences in Two Large Mycobacterium tuberculosis Genotype Clusters in Isolates Collected from Homeless Patients in New York City from 2001 to 2004.. J. Clin. Microbiol.
44: 2890-2896
[Abstract][Full Text]
Driver, C. R., Macaraig, M., McElroy, P. D., Clark, C., Munsiff, S. S., Kreiswirth, B., Driscoll, J., Zhao, B.
(2006). Which Patients' Factors Predict the Rate of Growth of Mycobacterium tuberculosis Clusters in an Urban Community?. Am J Epidemiol
164: 21-31
[Abstract][Full Text]
Hervas-Stubbs, S., Majlessi, L., Simsova, M., Morova, J., Rojas, M.-J., Nouze, C., Brodin, P., Sebo, P., Leclerc, C.
(2006). High Frequency of CD4+ T Cells Specific for the TB10.4 Protein Correlates with Protection against Mycobacterium tuberculosis Infection.. Infect. Immun.
74: 3396-3407
[Abstract][Full Text]
Tufariello, J. M., Mi, K., Xu, J., Manabe, Y. C., Kesavan, A. K., Drumm, J., Tanaka, K., Jacobs, W. R. Jr., Chan, J.
(2006). Deletion of the Mycobacterium tuberculosis Resuscitation-Promoting Factor Rv1009 Gene Results in Delayed Reactivation from Chronic Tuberculosis.. Infect. Immun.
74: 2985-2995
[Abstract][Full Text]
Stewart, J. N., Rivera, H. N., Karls, R., Quinn, F. D., Roman, J., Rivera-Marrero, C. A.
(2006). Increased pathology in lungs of mice after infection with an {alpha}-crystallin mutant of Mycobacterium tuberculosis: changes in cathepsin proteases and certain cytokines. Microbiology
152: 233-244
[Abstract][Full Text]
(2005). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States. Am. J. Respir. Crit. Care Med.
172: 1169-1227
[Full Text]
MacNeil, J. R., Lobato, M. N., Moore, M.
(2005). An Unanswered Health Disparity: Tuberculosis Among Correctional Inmates, 1993 Through 2003. AJPH
95: 1800-1805
[Abstract][Full Text]
Sherwood, J. T., Mitchell, J. D., Pomerantz, M.
(2005). Completion pneumonectomy for chronic mycobacterial disease. J. Thorac. Cardiovasc. Surg.
129: 1258-1265
[Abstract][Full Text]
Dlodlo, R. A., Fujiwara, P. I., Enarson, D. A.
(2005). Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?. Eur Respir J
25: 751-757
[Abstract][Full Text]
Shen, Y., Shen, L., Sehgal, P., Huang, D., Qiu, L., Du, G., Letvin, N. L., Chen, Z. W.
(2004). Clinical Latency and Reactivation of AIDS-Related Mycobacterial Infections. J. Virol.
78: 14023-14032
[Abstract][Full Text]
Pearl, J. E., Khader, S. A., Solache, A., Gilmartin, L., Ghilardi, N., deSauvage, F., Cooper, A. M.
(2004). IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice. J. Immunol.
173: 7490-7496
[Abstract][Full Text]
Santucci, M.B., Bocchino, M., Garg, S.K., Marruchella, A., Colizzi, V., Saltini, C., Fraziano, M.
(2004). Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur Respir J
24: 638-643
[Abstract][Full Text]
Pediatric Tuberculosis Collaborative Group,
(2004). Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents. Pediatrics
114: 1175-1201
[Abstract][Full Text]
Horsburgh, C. R. Jr.
(2004). Priorities for the Treatment of Latent Tuberculosis Infection in the United States. NEJM
350: 2060-2067
[Abstract][Full Text]
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M., Barry, C. E. III, Bekker, L.-G.
(2003). Mycobacterium tuberculosis Growth at the Cavity Surface: a Microenvironment with Failed Immunity. Infect. Immun.
71: 7099-7108
[Abstract][Full Text]
Cahn, P., Perez, H., Ben, G., Ochoa, C.
(2003). Tuberculosis and HIV: A Partnership Against the Most Vulnerable. J Int Assoc Physicians AIDS Care (Chic Ill)
2: 106-123
[Abstract]
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., Dye, C.
(2003). The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic. Arch Intern Med
163: 1009-1021
[Abstract][Full Text]
Condos, R., Raju, B., Canova, A., Zhao, B.-Y., Weiden, M., Rom, W. N., Pine, R.
(2003). Recombinant Gamma Interferon Stimulates Signal Transduction and Gene Expression in Alveolar Macrophages In Vitro and in Tuberculosis Patients. Infect. Immun.
71: 2058-2064
[Abstract][Full Text]
Lazarevic, V., Flynn, J.
(2002). CD8+ T Cells in Tuberculosis. Am. J. Respir. Crit. Care Med.
166: 1116-1121
[Full Text]
Narita, M., Kellman, M., Franchini, D. L., McMillan, M. E., Hollender, E. S., Ashkin, D.
(2002). Short-Course Rifamycin and Pyrazinamide Treatment for Latent Tuberculosis Infection in Patients With HIV Infection: The 2-Year Experience of a Comprehensive Community-Based Program in Broward County, Florida. Chest
122: 1292-1298
[Abstract][Full Text]
Schluger, N. W., Perez, D., Liu, Y. M.
(2002). Reconstitution of Immune Responses to Tuberculosis in Patients With HIV Infection Who Receive Antiretroviral Therapy*. Chest
122: 597-602
[Abstract][Full Text]
White, M. C., Tulsky, J. P., Goldenson, J., Portillo, C. J., Kawamura, M., Menendez, E.
(2002). Randomized Controlled Trial of Interventions to Improve Follow-up for Latent Tuberculosis Infection After Release From Jail. Arch Intern Med
162: 1044-1050
[Abstract][Full Text]
Bruchfeld, J., Aderaye, G., Palme, I. B., Bjorvatn, B., Ghebremichael, S., Hoffner, S., Lindquist, L.
(2002). Molecular Epidemiology and Drug Resistance of Mycobacterium tuberculosis Isolates from Ethiopian Pulmonary Tuberculosis Patients with and without Human Immunodeficiency Virus Infection. J. Clin. Microbiol.
40: 1636-1643
[Abstract][Full Text]
Schwartzman, K.
(2002). Latent tuberculosis infection: old problem, new priorities. CMAJ
166: 759-761
[Full Text]
(2002). Tuberculosis and HIV. AIDS Clin Care
2002: 6-6
[Full Text]
Bothamley, G H, Rowan, J P, Griffiths, C J, Beeks, M, McDonald, M, Beasley, E, van den Bosch, C, Feder, G
(2002). Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax
57: 45-49
[Abstract][Full Text]
Shen, Y., Shen, L., Sehgal, P., Zhou, D., Simon, M., Miller, M., Enimi, E. A., Henckler, B., Chalifoux, L., Sehgal, N., Gastron, M., Letvin, N. L., Chen, Z. W.
(2001). Antiretroviral Agents Restore Mycobacterium-Specific T-Cell Immune Responses and Facilitate Controlling a Fatal Tuberculosis-Like Disease in Macaques Coinfected with Simian Immunodeficiency Virus and Mycobacterium bovis BCG. J. Virol.
75: 8690-8696
[Abstract][Full Text]
Barr, R. G., Diez-Roux, A. V., Knirsch, C. A., Pablos-Mendez, A.
(2001). Neighborhood Poverty and the Resurgence of Tuberculosis in New York City, 1984-1992. AJPH
91: 1487-1493
[Abstract][Full Text]
Flynn, J. L., Chan, J.
(2001). Tuberculosis: Latency and Reactivation. Infect. Immun.
69: 4195-4201
[Full Text]
RILEY, E. D., CHAISSON, R. E., ROBNETT, T. J., VERTEFEUILLE, J., STRATHDEE, S. A., VLAHOV, D.
(2001). Use of Audio Computer-assisted Self-Interviews to Assess Tuberculosis-related Risk Behaviors. Am. J. Respir. Crit. Care Med.
164: 82-85
[Abstract][Full Text]
MOSS, A. R., HAHN, J. A., TULSKY, J. P., DALEY, C. L., SMALL, P. M., HOPEWELL, P. C.
(2000). Tuberculosis in the Homeless . A Prospective Study. Am. J. Respir. Crit. Care Med.
162: 460-464
[Abstract][Full Text]
Vynnycky, E., Fine, P. E. M.
(2000). Lifetime Risks, Incubation Period, and Serial Interval of Tuberculosis. Am J Epidemiol
152: 247-263
[Abstract][Full Text]
Schwander, S. K., Torres, M., Carranza C, C., Escobedo, D., Tary-Lehmann, M., Anderson, P., Toossi, Z., Ellner, J. J., Rich, E. A., Sada, E.
(2000). Pulmonary Mononuclear Cell Responses to Antigens of Mycobacterium tuberculosis in Healthy Household Contacts of Patients with Active Tuberculosis and Healthy Controls from the Community. J. Immunol.
165: 1479-1485
[Abstract][Full Text]
Hendrickson, R. C., Douglass, J. F., Reynolds, L. D., McNeill, P. D., Carter, D., Reed, S. G., Houghton, R. L.
(2000). Mass Spectrometric Identification of Mtb81, a Novel Serological Marker for Tuberculosis. J. Clin. Microbiol.
38: 2354-2361
[Abstract][Full Text]
Lauzardo, M., Ashkin, D.
(2000). Phthisiology at the Dawn of the New Century. Chest
117: 1455-1473
[Abstract][Full Text]
Slovis, B. S., Plitman, J. D., Haas, D. W.
(2000). The Case Against Anergy Testing as a Routine Adjunct to Tuberculin Skin Testing. JAMA
283: 2003-2007
[Abstract][Full Text]
(2000). Diagnostic Standards and Classification of Tuberculosis in Adults and Children . This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med.
161: 1376-1395
[Full Text]
(2000). Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection . This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This Statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this Statement as it relates to infants and children were endorsed by the American Academy of Pediatrics (AAP), August 1999.. Am. J. Respir. Crit. Care Med.
161: S221-247
[Full Text]
Kimerling, M. E., Barker, J. T., Bruce, F., Brook, N. L., Dunlap, N. E.
(2000). Preventable Childhood Tuberculosis in Alabama: Implications and Opportunity. Pediatrics
105: 53e-53
[Abstract][Full Text]
Gordin, F., Chaisson, R. E., Matts, J. P., Miller, C., Garcia, M. d. L., Hafner, R., Valdespino, J. L., Coberly, J., Schechter, M., Klukowicz, A. J., Barry, M. A., O'Brien, R. J., for the Terry Beirn Community Programs for Clinica,
(2000). Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons: An International Randomized Trial. JAMA
283: 1445-1450
[Abstract][Full Text]
Keizer, S. T, Langendam, M. M W, van Deutekom, H., Coutinho, R. A, van Ameijden, E. J C
(2000). How does tuberculosis relate to HIV positive and HIV negative drug users?. J. Epidemiol. Community Health
54: 64-68
[Abstract][Full Text]
Demissie, A., Ravn, P., Olobo, J., Doherty, T. M., Eguale, T., Geletu, M., Hailu, W., Andersen, P., Britton, S.
(1999). T-Cell Recognition of Mycobacterium tuberculosis Culture Filtrate Fractions in Tuberculosis Patients and Their Household Contacts. Infect. Immun.
67: 5967-5971
[Abstract][Full Text]
Kulaga, S., Behr, M. A., Schwartzman, K.
(1999). Genetic fingerprinting in the study of tuberculosis transmission. CMAJ
161: 1165-1169
[Full Text]
Floyd, K., Reid, R. A., Wilkinson, D., Gilks, C. F.
(1999). Admission Trends in a Rural South African Hospital During the Early Years of the HIV Epidemic. JAMA
282: 1087-1091
[Abstract][Full Text]
Miyazaki, E., Chaisson, R. E., Bishai, W. R.
(1999). Analysis of Rifapentine for Preventive Therapy in the Cornell Mouse Model of Latent Tuberculosis. Antimicrob. Agents Chemother.
43: 2126-2130
[Abstract][Full Text]
GOLDBERG, S. V., DUCHIN, J. S., SHIELDS, T., NOLAN, C. M.
(1999). Four-Month, Four-Drug Preventive Therapy for Inactive Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med.
160: 508-512
[Abstract][Full Text]
Berger, A. R., Schaumburg, H. H., Gourevitch, M. N., Freeman, K., Herskovitz, S., Arezzo, J. C.
(1999). Prevalence of peripheral neuropathy in injection drug users. Neurology
53: 592-592
[Abstract][Full Text]
FitzGerald, J. M., Houston, S.
(1999). Tuberculosis: 8. The disease in association with HIV infection. CMAJ
161: 47-51
[Abstract][Full Text]
SNYDER, D. C., PAZ, E. A., MOHLE-BOETANI, J. C., FALLSTAD, R., BLACK, R. L., CHIN, D. P.
(1999). Tuberculosis Prevention in Methadone Maintenance Clinics . Effectiveness and Cost-Effectiveness. Am. J. Respir. Crit. Care Med.
160: 178-185
[Abstract][Full Text]
MAYAUD, C, CADRANEL, J
(1999). Tuberculosis in AIDS: past or new problems?. Thorax
54: 567-571
[Full Text]
Rhee, J. T., Piatek, A. S., Small, P. M., Harris, L. M., Chaparro, S. V., Kramer, F. R., Alland, D.
(1999). Molecular Epidemiologic Evaluation of Transmissibility and Virulence of Mycobacterium tuberculosis. J. Clin. Microbiol.
37: 1764-1770
[Abstract][Full Text]
BARNES, P. F., YANG, Z., POGODA, J. M., PRESTON-MARTIN, S., JONES, B. E., OTAYA, M., KNOWLES, L., HARVEY, S., EISENACH, K. D., DONALD CAVE, M.
(1999). Foci of Tuberculosis Transmission in Central Los Angeles. Am. J. Respir. Crit. Care Med.
159: 1081-1086
[Abstract][Full Text]
Meddows-Taylor, S., Martin, D. J., Tiemessen, C. T.
(1999). Dysregulated Production of Interleukin-8 in Individuals Infected with Human Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis. Infect. Immun.
67: 1251-1260
[Abstract][Full Text]
Zhou, D., Shen, Y., Chalifoux, L., Lee-Parritz, D., Simon, M., Sehgal, P. K., Zheng, L., Halloran, M., Chen, Z. W.
(1999). Mycobacterium bovis Bacille Calmette-Guerin Enhances Pathogenicity of Simian Immunodeficiency Virus Infection and Accelerates Progression to AIDS in Macaques: A Role of Persistent T cell Activation in AIDS Pathogenesis. J. Immunol.
162: 2204-2216
[Abstract][Full Text]
Havlir, D. V., Barnes, P. F.
(1999). Tuberculosis in Patients with Human Immunodeficiency Virus Infection. NEJM
340: 367-373
[Full Text]
SANDMAN, L., SCHLUGER, N. W., DAVIDOW, A. L., BONK, S.
(1999). Risk Factors for Rifampin-monoresistant Tuberculosis . A Case-Control Study. Am. J. Respir. Crit. Care Med.
159: 468-472
[Abstract][Full Text]
Leung, A. N.
(1999). Pulmonary Tuberculosis: The Essentials. Radiology
210: 307-322
[Full Text]
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., Bloom, B. R.
(1998). A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA
95: 15688-15693
[Abstract][Full Text]
CHIN, D. P., DERIEMER, K., SMALL, P. M., de LEON, A. P., STEINHART, R., SCHECTER, G. F., DALEY, C. L., MOSS, A. R., PAZ, E. A., JASMER, R. M., AGASINO, C. B., HOPEWELL, P. C.
(1998). Differences in Contributing Factors to Tuberculosis Incidence in U.S.-born and Foreign-born Persons. Am. J. Respir. Crit. Care Med.
158: 1797-1803
[Abstract][Full Text]
Sawert, H., Girardi, E., Antonucci, G., Raviglione, M. C., Viale, P., Ippolito, G., for the Gruppo Italiano di Studio Tubercolosi e AI,
(1998). Preventive Therapy for Tuberculosis in HIV-Infected Persons: Analysis of Policy Options Based on Tuberculin Status and CD4+Cell Count. Arch Intern Med
158: 2112-2121
[Abstract][Full Text]
Gomez-Moreno, J., Cuervas-Mons, V., Ridzon, R., Onorato, I. M., Palmer, S. M., Tapson, V. F., Stamm, A. M., Fishman, J. A., Rubin, R. H.
(1998). Infection in Organ-Transplant Recipients. NEJM
339: 1244-1246
[Full Text]
Wilkinson, D., Squire, S B, Garner, P.
(1998). Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ
317: 625-629
[Abstract][Full Text]
CHITWOOD, D. D., McBRIDE, D. C., METSCH, L. R., COMERFORD, M., McCOY, C. B.
(1998). A Comparison of the Need for Health Care and Use of Health Care by Injection-Drug Users, Other Chronic Drug Users, and Nondrug Users. American Behavioral Scientist
41: 1107-1122
[Abstract]
SCHLUGER, N. W., ROM, W. N.
(1998). The Host Immune Response to Tuberculosis. Am. J. Respir. Crit. Care Med.
157: 679-691
[Full Text]
Flynn, J. L., Scanga, C. A., Tanaka, K. E., Chan2, J.
(1998). Effects of Aminoguanidine on Latent Murine Tuberculosis. J. Immunol.
160: 1796-1803
[Abstract][Full Text]
Sheets, E. E., Smith, R. N.
(1998). Case 3-1998- A 31-Year-Old Woman with a Pleural Effusion, Ascites, and Persistent Fever Spikes. NEJM
338: 248-254
[Full Text]
McKeogh, M. M
(1997). Tuberculosis in the hospice a cause for concern?. Palliat Med
11: 469-474
[Abstract]
Lincoln, T., Lynch, V., Conklin, T. J.
(1997). Skin Anergy Testing and Tuberculosis Surveillance. J Correct Health Care
4: 139-153
[Abstract]
Whalen, C. C., Johnson, J. L., Okwera, A., Hom, D. L., Huebner, R., Mugyenyi, P., Mugerwa, R. D., Ellner, J. J., Nsubuga, P., Vjecha, M., Myanja, H., Kityo, C., Loughlin, A., Milberg, J., Pekovic, V., The Uganda-Case Western Reserve University Researc,
(1997). A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus. NEJM
337: 801-808
[Abstract][Full Text]
Moreno, S., Miralles, P., Diaz, M. D., Baraia, J., Padilla, B., Berenguer, J., Alberdi, J. C.
(1997). Isoniazid Preventive Therapy in Human Immunodeficiency Virus-Infected Persons: Long-term Effect on Development of Tuberculosis and Survival. Arch Intern Med
157: 1729-1734
[Abstract]
Gordin, F. M., Matts, J. P., Miller, C., Brown, L. S., Hafner, R., John, S. L., Klein, M., Vaughn, A., Besch, C. L., Perez, G., Szabo, S., El-Sadr, W., The Terry Beirn Community Programs for Clinical Re,
(1997). A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis. NEJM
337: 315-320
[Abstract][Full Text]
Bangsberg, D., Tulsky, J. P., Hecht, F. M., Moss, A. R.
(1997). Protease Inhibitors in the Homeless. JAMA
278: 63-65
[Abstract]
Macher, A. M., Goosby, E. P.
(1997). Inmate Access to Postrelease Medical Care: Public Health Implications. Arch Fam Med
6: 318-318
[Abstract]
Girardi, E., Antonucci, G., Ippolito, G., Raviglione, M. C., Rapiti, E., Perri, G. D., Babudieri, S.
(1997). Association of Tuberculosis Risk With the Degree of Tuberculin Reaction in HIV-Infected Patients. Arch Intern Med
157: 797-800
[Abstract]
DALEY, C. L., HAHN, J. A., MOSS, A. R., HOPEWELL, P. C., SCHECTER, G. F.
(1997). Incidence of Tuberculosis in Injection Drug Users in San Francisco . Impact of Anergy. Am. J. Respir. Crit. Care Med.
157: 19-22
[Abstract][Full Text]
Brewer, T. F., Heymann, S. J., Colditz, G. A., Wilson, M. E., Auerbach, K., Kane, D., Fineberg, H. V.
(1996). Evaluation of Tuberculosis Control Policies Using Computer Simulation. JAMA
276: 1898-1903
[Abstract]
Sanchez-portocarrero, J., Perez-Cecilia, E., Jimenez-Escrig, A., Martin-Rabadan, P., Roca, V., Yague, M. R., Romero-Vivas, J., Palau, E., Picazo, J. J.
(1996). Tuberculous Meningitis: Clinical Characteristics and Comparison With Cryptococcal Meningitis in Patients With Human Immunodeficiency Virus Infection. Arch Neurol
53: 671-676
[Abstract]
Graham, N. M. H., Galai, N., Nelson, K. E., Astemborski, J., Bonds, M., Rizzo, R. T., Sheeley, L., Vlahov, D.
(1996). Effect of Isoniazid Chemoprophylaxis on HIV-Related Mycobacterial Disease. Arch Intern Med
156: 889-894
[Abstract]
(1996). Surveillance of Tuberculosis and AIDS Co-Morbidity--Florida, 1981-1993. Arch Dermatol
132: 377-378
[Abstract]
Friedman, L. N., Williams, M. T., Singh, T. P., Frieden, T. R.
(1996). Tuberculosis, AIDS, and Death among Substance Abusers on Welfare in New York City. NEJM
334: 828-833
[Abstract][Full Text]
WATTS, H. G., LIFESO, R. M.
(1996). Current Concepts Review - Tuberculosis of Bones and Joints. JBJS
78: 288-99
[Full Text]
Curtis, J. R., Paauw, D. S., Wenrich, M. D., Carline, J. D., Ramsey, P. G.
(1995). Physicians' Ability to Provide Initial Primary Care to an HIV-Infected Patient. Arch Intern Med
155: 1613-1618
[Abstract]
Antonucci, G., Girardi, E., Raviglione, M. C., Ippolito, G., for the Gruppo Italiano di Studio Tubercolosi e AI, , Almi, P., Angarano, G., Armignacco, O., Babudieri, S., Bevilacqua, N., Bini, A., Bottura, P., Boumis, E., Costigliola, P., Chirianni, A., Di Perri, G., Errante, I., Libanore, M., Manzillo, E., Minoli, L., Narciso, P., Pagano, G., Pellizzer, G., Rapiti, E., Rusconi, S., Santoro, D., Savalli, E., Tavio, M., Traverso, A., Viale, P.
(1995). Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study. JAMA
274: 143-148
[Abstract]
Burwen, D. R., Bloch, A. B., Griffin, L. D., Ciesielski, C. A., Stern, H. A., Onorato, I. M.
(1995). National Trends in the Concurrence of Tuberculosis and Acquired Immunodeficiency Syndrome. Arch Intern Med
155: 1281-1286
[Abstract]
Walley, J., Porter, J.
(1995). Chemoprophylaxis in tuberculosis and HIV infection. BMJ
310: 1621-1622
[Full Text]
Mofenson, L. M., Rodriguez, E. M., Hershow, R., Fox, H. E., Landesman, S., Tuomala, R., Diaz, C., Daniels, E., Brambilla, D., Women and Infants Transmission Study Group,
(1995). Mycobacterium tuberculosis Infection in Pregnant and Nonpregnant Women Infected With HIV in the Women and Infants Transmission Study. Arch Intern Med
155: 1066-1072
[Abstract]
Raviglione, M. C., Snider, D. E. Jr, Kochi, A.
(1995). Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic. JAMA
273: 220-226
[Abstract]
